Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramCHIEF MEDICAL OFFICERCIK 0001701247
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 5,000 sh | Oct 21, 2026 traded Oct 19, 2026 | |
Collins Helen LouiseCHIEF MEDICAL OFFICER |
| ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $192K 5,000 sh |
| Oct 21, 2026 traded Oct 19, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Oct 21, 2026 traded Oct 19, 2026 |
| 3 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $146K 2,916 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 13 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $94K 1,844 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 6 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 240 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 5,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 1 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,413 140 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 0 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $117K 2,441 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $115K 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 14 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $99K 40.0K sh | Mar 27, 2026 traded Mar 25, 2026 |
| 26 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.40M 40.0K sh | Mar 27, 2026 traded Mar 25, 2026 |
| 7 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 40.0K sh | Mar 27, 2026 traded Mar 25, 2026 |